ADAMA Reports $933 Million in Q3 Sales with 50% EBITDA Growth in 2025

03 November 2025, Beijing: ADAMA Ltd. has reported its financial results for the third quarter and first nine months of 2025 that ended September 30, 2025.

Third Quarter 2025 Highlights:

• Stable Sales(0% in USD, 1% in RMB) of $933 million, reflecting the combined results of a 1% increase in volume and a 1% decrease in prices 
• Adjusted gross profit up 14% to $257 million, representing an improvement of gross margin to 27.6% from 24.2% last year, reflecting the benefits of lower costsand higher volumes
• Adjusted EBITDA up 50% to $120 million, representing an improvement of EBITDA margin to 12.9% from 8.6% last year 
• Adjusted net lossreduced to $20 million from $78 million last year; Reported net loss improved by $85 million to $48million compared to $133 million last year

First Nine Months 2025 Highlights:

• StableSales (0% in USD, 1% in RMB) of $3,025 million, reflecting the combined results of a 3% increase in volume and a 3% decrease in prices
• Adjusted gross profit up 12% to $878million, representing an improvement of gross margin to 29.0% from 25.8% last year, reflecting the benefits of lower costs and higher volumes
• Adjusted EBITDA up 30% to $430million, representing an improvement of EBITDA margin to 14.2% from 11.0% last year 
• Adjusted net income turned positive to $29million compared to a loss of $149 million last year; Reported net lossimproved by $200 million to $59 million compared to $259 million last year
• Operating cash flowof $331 million generated vs. $402 million last year
• Free cash flowof $112 million vs. $179 million last year

Gaël Hili, President and CEO of ADAMA, said, “In the third quarter, we continued to deliver improved financial results with stable sales and our sixth consecutive quarter of year-over-year EBITDA growth, clear indicators that our Fight Forward transformation plan is delivering results in support of our value innovation strategy. We remain focused on strengthening our operational foundations, enhancing commercial execution, and driving innovation across our portfolio, delivering meaningful impact for farmers and positioning ADAMA for sustainable, long-term profitable growth.”

Also Read: EPA Issues Proposed Registration Decision for Biotalys’ EVOCA™ Biofungicide

📢 If You’re in Agriculture, Make Sure the Right People Hear Your Story.
From product launches to strategic announcements, Global Agriculture offers unmatched visibility across international agri-business markets. Connect with us at pr@global-agriculture.com to explore editorial and advertising opportunities that reach the right audience, worldwide.